17:13 EST QuidelOrtho (QDEL) sees ‘significant growth opportunities’ outside U.S.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL:
- QuidelOrtho says targeting mid-to-high 20% adjusted EBITDA margins
- QuidelOrtho sees FY25 COVID-19 revenue of $70M-$100M
- QuidelOrtho reports Q3 adjusted EPS 80c, consensus 47c
- QuidelOrtho sees FY25 adjusted EPS $2.00-$2.15, consensus $2.24
- QuidelOrtho receives FDA 510(k) clearance for VITROS hs Troponin I Assay